Eating blueberries daily may decrease blood pressure
the ONA take:
According to a new study published in the Journal of the Academy of Nutrition and Dietetics, researchers at Florida State University in Tallahassee, Florida, have found that eating blueberries daily may decrease both systolic and diastolic blood pressures.
For the double-blind, placebo-controlled study, researchers enrolled 48 postmenopausal women with pre- and stage 1-hypertension and randomly assigned them to consume freeze-dried blueberry powder equivalent to one cup of fresh blueberries daily or placebo for 8 weeks.
Results showed that in the blueberry group, mean systolic blood pressure and mean diastolic blood pressure had decreased by 5.1% and 6.3%, respectively, compared with no change in blood pressure in the control group. In addition, they found that blueberry consumption improved arterial stiffness possibly due to enhanced nitric oxide-mediated vasodilation.
The recommended treatment for patients with pre- and stage 1-hypertension is lifestyle modification, such as dietary changes, rather than medication.
The DASH diet, which focuses on a diet rich in fruits and vegetables, has been consistently ranked the best diet to reduce blood pressure. The findings of this study suggest that blueberries have a promising beneficial effect on vascular health and should be included in one's diet to prevent hypertension.
Eating blueberries daily may decrease both systolic and diastolic blood pressures.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|